The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Uric Acid as a Target of Therapy in CKD
Open accessAbstract
The prevalence of chronic kidney disease (CKD) has risen and will continue to rise in the United States and worldwide. This is alarming considering that CKD remains an irreversible condition and patients who progress to chronic kidney failure suffer reduced quality of life and high mortality rates. As such, it is imperative to identify modifiable risk factors to develop strategies to slow CKD progression. One such factor is hyperuricemia. Recent observational studies have associated hyperuricemia with kidney disease. In addition, hyperuricemia is largely prevalent in patients with CKD. Data from experimental studies have revealed several potential mechanisms by which hyperuricemia may contribute to the development and progression of CKD. In this manuscript we offer a critical review of the experimental evidence linking hyperuricemia to CKD, we highlight the gaps in our knowledge on the topic as it stands today, and we review the observational and interventional studies that have examined the potential nephro-protective effect of lowering uric acid in CKD patients . While uric acid may also be linked to cardiovascular disease and mortality in patients with CKD, this review will focus only on uric acid as a potential therapeutic target to prevent kidney disease onset and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,909
Molecular identification of a renal urate–anion exchanger that regulates blood urate levels
Enomoto, A., Kimura, H., Chairoungdua, A., Shigeta, Y., Jutabha, P., Ho Cha, S., Hosoyamada, M., Takeda, M., Sekine, T., Igarashi, T., et al. (2002) · Nature · doi:10.1038/nature742 · Cited by 1,535
Levey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
A Role for Uric Acid in the Progression of Renal Disease
Kang, D.-H., Nakagawa, T., Feng, L., Watanabe, S., Han, L., Mazzali, M., Truong, L., Harris, R., & Johnson, R. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034910.58454.fd · Cited by 1,304
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Feig, D. I., Soletsky, B., & Johnson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.924 · Cited by 914
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Mazzali, M., Kanellis, J., Han, L., Feng, L., Xia, Y.-Y., Chen, Q., Kang, D.-H., Gordon, K. L., Watanabe, S., Nakagawa, T., et al. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00283.2001 · Cited by 826
Hande, K. R., Noone, R. M., & Stone, W. J. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90743-5 · Cited by 680
Elevated Uric Acid Increases the Risk for Kidney Disease
Obermayr, R. P., Temml, C., Gutjahr, G., Knechtelsdorfer, M., Oberbauer, R., & Klauser-Braun, R. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010080 · Cited by 647
Risk Factors for End-Stage Renal Disease: 25-Year Follow-up
Hsu, C.-Y., Iribarren, C., McCulloch, C. E., Darbinian, J., & Go, A. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.605 · Cited by 589
Becker, M. A., Schumacher, H. R., Espinoza, L. R., Wells, A. F., MacDonald, P., Lloyd, E., & Lademacher, C. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2978 · Cited by 529
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
Iseki, K., Ikemiya, Y., Inoue, T., Iseki, C., Kinjo, K., & Takishita, S. (2004) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(04)00934-5 · Cited by 526
Uric Acid and Incident Kidney Disease in the Community
Weiner, D. E., Tighiouart, H., Elsayed, E. F., Griffith, J. L., Salem, D. N., & Levey, A. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101075 · Cited by 462
Shoji, A., Yamanaka, H., & Kamatani, N. (2004) · Arthritis Care & Research · doi:10.1002/art.20405 · Cited by 438
Uric Acid and Long-term Outcomes in CKD
Madero, M., Sarnak, M. J., Wang, X., Greene, T., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Menon, V. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.12.021 · Cited by 436
Relationship of Uric Acid With Progression of Kidney Disease
Chonchol, M., Shlipak, M. G., Katz, R., Sarnak, M. J., Newman, A. B., Siscovick, D. S., Kestenbaum, B., Carney, J. K., & Fried, L. F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.013 · Cited by 420
Self-citationAlvarez-Lario, B., & Macarron-Vicente, J. (2010) · Rheumatology · doi:10.1093/rheumatology/keq204 · Cited by 391
ISEKI, K., OSHIRO, S., TOZAWA, M., ISEKI, C., IKEMIYA, Y., & TAKISHITA, S. (2001) · Hypertension Research · doi:10.1291/hypres.24.691 · Cited by 386
Kanbay, M., Ozkara, A., Selcoki, Y., Isik, B., Turgut, F., Bavbek, N., Uz, E., Akcay, A., Yigitoglu, R., & Covic, A. (2007) · International Urology and Nephrology · doi:10.1007/s11255-007-9253-3 · Cited by 325
Eijkelkamp, W. B. A., Zhang, Z., Remuzzi, G., Parving, H.-H., Cooper, M. E., Keane, W. F., Shahinfar, S., Gleim, G. W., Weir, M. R., Brenner, B. M., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050445 · Cited by 302
Preitner, F., Bonny, O., Laverrière, A., Rotman, S., Firsov, D., Da Costa, A., Metref, S., & Thorens, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904411106 · Cited by 284
Zoppini, G., Targher, G., Chonchol, M., Ortalda, V., Abaterusso, C., Pichiri, I., Negri, C., & Bonora, E. (2012) · Diabetes Care · doi:10.2337/dc11-1346 · Cited by 274
Self-citationIshani, A., Grandits, G. A., Grimm, R. H., Svendsen, K. H., Collins, A. J., Prineas, R. J., & Neaton, J. D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005091012 · Cited by 272
Association of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals
Bellomo, G., Venanzi, S., Verdura, C., Saronio, P., Esposito, A., & Timio, M. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.01.019 · Cited by 260
Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy
Syrjänen, J., Mustonen, J., & Pasternack, A. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.1.34 · Cited by 257
Inactivation of Nitric Oxide by Uric Acid
Gersch, C., Palii, S. P., Kim, K. M., Angerhofer, A., Johnson, R. J., & Henderson, G. N. (2008) · Nucleosides, Nucleotides and Nucleic Acids · doi:10.1080/15257770802257952 · Cited by 253
Kanbay, M., Huddam, B., Azak, A., Solak, Y., Kadioglu, G. K., Kirbas, I., Duranay, M., Covic, A., & Johnson, R. J. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11451210 · Cited by 248
Zharikov, S., Krotova, K., Hu, H., Baylis, C., Johnson, R. J., Block, E. R., & Patel, J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00075.2008 · Cited by 239
Ficociello, L. H., Rosolowsky, E. T., Niewczas, M. A., Maselli, N. J., Weinberg, J. M., Aschengrau, A., Eckfeldt, J. H., Stanton, R. C., Galecki, A. T., Doria, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0227 · Cited by 218
Serum Uric Acid as a Predictor for Development of Diabetic Nephropathy in Type 1 Diabetes
Hovind, P., Rossing, P., Tarnow, L., Johnson, R. J., & Parving, H.-H. (2009) · Diabetes · doi:10.2337/db09-0014 · Cited by 215
Conceptual Model of CKD: Applications and Implications
Levey, A. S., Stevens, L. A., & Coresh, J. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.07.048 · Cited by 209
Domrongkitchaiporn, S., Sritara, P., Kitiyakara, C., Stitchantrakul, W., Krittaphol, V., Lolekha, P., Cheepudomwit, S., & Yipintsoi, T. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004030208 · Cited by 209
Miao, Y., Ottenbros, S. A., Laverman, G. D., Brenner, B. M., Cooper, M. E., Parving, H.-H., Grobbee, D. E., Shahinfar, S., de Zeeuw, D., & Lambers Heerspink, H. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.171488 · Cited by 182
Talaat, K. M., & El-Sheikh, A. R. (2007) · American Journal of Nephrology · doi:10.1159/000105142 · Cited by 178
Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice
Kosugi, T., Nakayama, T., Heinig, M., Zhang, L., Yuzawa, Y., Sanchez-Lozada, L. G., Roncal, C., Johnson, R. J., & Nakagawa, T. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00092.2009 · Cited by 172
Sturm, G., Kollerits, B., Neyer, U., Ritz, E., & Kronenberg, F. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.01.006 · Cited by 170
Jalal, D. I., Rivard, C. J., Johnson, R. J., Maahs, D. M., McFann, K., Rewers, M., & Snell-Bergeon, J. K. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp740 · Cited by 170
Self-citationSerum Uric Acid and Renal Prognosis in Patients with IgA Nephropathy
Ohno, I., Hosoya, T., Gomi, H., Ichida, K., Okabe, H., & Hikita, M. (2001) · Nephron · doi:10.1159/000045939 · Cited by 169
Shi, Y., Chen, W., Jalal, D., Li, Z., Chen, W., Mao, H., Yang, Q., Johnson, R. J., & Yu, X. (2012) · Kidney and Blood Pressure Research · doi:10.1159/000331453 · Cited by 166
Self-citationRosolowsky, E. T., Ficociello, L. H., Maselli, N. J., Niewczas, M. A., Binns, A. L., Roshan, B., Warram, J. H., & Krolewski, A. S. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04271007 · Cited by 161
Dalbeth, N., & Stamp, L. K. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00270.x · Cited by 153
Netea, M. G., Kullberg, B. J., Blok, W. L., et al. (1997) · Blood · doi:10.1182/blood.v89.2.577 · Cited by 150
Effects of acute and chronic l -arginine treatment in experimental hyperuricemia
Sánchez‐Lozada, L. G., Tapia, E., López-Molina, R., Nepomuceno‐Mejía, T., Soto, V., Ávila-Casado, C., Nakagawa, T., Johnson, R. J., Herrera-Acosta, J., & Franco, M. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00164.2006 · Cited by 139
A ‘complexity’ of urate transporters
Wright, A. F., Rudan, I., Hastie, N. D., & Campbell, H. (2010) · Kidney International · doi:10.1038/ki.2010.206 · Cited by 135
Effect of elevated serum uric acid on cisplatin-induced acute renal failure
Roncal, C. A., Mu, W., Croker, B. P., Reungjui, S., Ouyang, X., Tabah-Fisch, I. M., Johnson, R. J., & Ejaz, A. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00160.2006 · Cited by 132
Effect of allopurinol in decreasing proteinuria in type 2 diabetic patients.
Momeni, A., Shahidi, S., Seirafian, S., Taheri, S., & Kheiri, S. (2010) · Iranian Journal of Kidney Diseases · Cited by 130
A study of the natural history of diabetic kidney disease (DKD)
Altemtam, N., Russell, J., & Nahas, M. E. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr561 · Cited by 123
Uric Acid Levels Predict Future Development of Chronic Kidney Disease
Sonoda, H., Takase, H., Dohi, Y., & Kimura, G. (2011) · American Journal of Nephrology · doi:10.1159/000326848 · Cited by 108
Uric acid and calcium oxalate nephrolithiasis
Coe, F. L., & Coe, F. L. (1983) · Kidney International · doi:10.1038/ki.1983.172 · Cited by 108
Sánchez‐Lozada, L. G., Tapia, E., Soto, V., Ávila-Casado, C., Franco, M., Wessale, J. L., Zhao, L., & Johnson, R. J. (2008) · Nephron Physiology · doi:10.1159/000127837 · Cited by 107
Effect of chronic experimental renal insufficiency on urate metabolism.
Vaziri, N. D., Freel, R. W., & Hatch, M. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v641313 · Cited by 104
Xanthine Oxidoreductase Is an Endogenous Regulator of Cyclooxygenase-2
Ohtsubo, T., Rovira, I. I., Starost, M. F., Liu, C., & Finkel, T. (2004) · Circulation Research · doi:10.1161/01.res.0000149571.96304.36 · Cited by 99
Mazali, F. C., & Mazzali, M. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.08.012 · Cited by 86
Ohtsubo, T., Matsumura, K., Sakagami, K., Fujii, K., Tsuruya, K., Noguchi, H., Rovira, I. I., Finkel, T., & Iida, M. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.135152 · Cited by 77
Serum uric acid and chronic kidney disease: the Severance cohort study
Mok, Y., Lee, S., Kim, M. S., Cui, W., Moon, Y. M., & Jee, S. H. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr530 · Cited by 71
Adhesion of uric acid crystals to the surface of renal epithelial cells
Koka, R., Huang, E., & Lieske, J. C. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.6.f989 · Cited by 69
Akalin, E., Ganeshan, S. V., Winston, J. A., & Muntner, P. (2008) · Transplantation · doi:10.1097/tp.0b013e3181814f5b · Cited by 66
Pais, V. M., Lowe, G. F., Lallas, C. D., Preminger, G. M., & Assimos, D. G. (2006) · Urology · doi:10.1016/j.urology.2005.10.057 · Cited by 56
Management of Hyperuricemia and Gout in CKD
Gaffo, A., & Saag, K. G. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.07.035 · Cited by 33
Higher Incidence of ESRD than Mortality in the AASK Study
Fried, L. F. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060623 · Cited by 9
Cited by
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Johnson, R. J., Bakris, G. L., Borghi, C., Chonchol, M. B., Feldman, D., Lanaspa, M. A., Merriman, T. R., Moe, O. W., Mount, D. B., Sanchez Lozada, L. G., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2017.12.009 · Cited by 644
Self-citationEffects of Allopurinol on the Progression of Chronic Kidney Disease
Badve, S. V., Pascoe, E. M., Tiku, A., Boudville, N., Brown, F. G., Cass, A., Clarke, P., Dalbeth, N., Day, R. O., de Zoysa, J. R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915833 · Cited by 473
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kimura, K., Hosoya, T., Uchida, S., Inaba, M., Makino, H., Maruyama, S., Ito, S., Yamamoto, T., Tomino, Y., Ohno, I., et al. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.028 · Cited by 383
Metadata
- Authors
- Jalal, D. I., Chonchol, M., Chen, W., & Targher, G.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 61
- Issue
- 1
- Pages
- 134-146
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2061170857
- Cited by
- 268
- References
- 64
- FWCI
- 12.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.